182 related articles for article (PubMed ID: 31353103)
1. Delayed delivery of endothelial progenitor cell-derived extracellular vesicles via shear thinning gel improves postinfarct hemodynamics.
Chung JJ; Han J; Wang LL; Arisi MF; Zaman S; Gordon J; Li E; Kim ST; Tran Z; Chen CW; Gaffey AC; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2020 May; 159(5):1825-1835.e2. PubMed ID: 31353103
[TBL] [Abstract][Full Text] [Related]
2. Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction.
Chen CW; Wang LL; Zaman S; Gordon J; Arisi MF; Venkataraman CM; Chung JJ; Hung G; Gaffey AC; Spruce LA; Fazelinia H; Gorman RC; Seeholzer SH; Burdick JA; Atluri P
Cardiovasc Res; 2018 Jun; 114(7):1029-1040. PubMed ID: 29566124
[TBL] [Abstract][Full Text] [Related]
3. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.
Gaffey AC; Chen MH; Venkataraman CM; Trubelja A; Rodell CB; Dinh PV; Hung G; MacArthur JW; Soopan RV; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1268-76. PubMed ID: 26293548
[TBL] [Abstract][Full Text] [Related]
4. Delivery of progenitor cells with injectable shear-thinning hydrogel maintains geometry and normalizes strain to stabilize cardiac function after ischemia.
Gaffey AC; Chen MH; Trubelja A; Venkataraman CM; Chen CW; Chung JJ; Schultz S; Sehgal CM; Burdick JA; Atluri P
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1479-1490. PubMed ID: 30579534
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles from human embryonic stem cell-derived cardiovascular progenitor cells promote cardiac infarct healing through reducing cardiomyocyte death and promoting angiogenesis.
Wu Q; Wang J; Tan WLW; Jiang Y; Wang S; Li Q; Yu X; Tan J; Liu S; Zhang P; Tiang Z; Chen Z; Foo RS; Yang HT
Cell Death Dis; 2020 May; 11(5):354. PubMed ID: 32393784
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Efficacy of Cryopreserved, Allogeneic Extracellular Vesicles for Treatment of Acute Myocardial Infarction.
Chung JJ; Kim ST; Zaman S; Helmers MR; Arisi MF; Li EC; Tran Z; Chen CW; Altshuler P; Chen M; Burdick JA; Atluri P
Int Heart J; 2021 Mar; 62(2):381-389. PubMed ID: 33731514
[TBL] [Abstract][Full Text] [Related]
7. Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.
Atluri P; Miller JS; Emery RJ; Hung G; Trubelja A; Cohen JE; Lloyd K; Han J; Gaffey AC; MacArthur JW; Chen CS; Woo YJ
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1090-7; discussion 1097-8. PubMed ID: 25129603
[TBL] [Abstract][Full Text] [Related]
8. Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction.
Jamaiyar A; Wan W; Ohanyan V; Enrick M; Janota D; Cumpston D; Song H; Stevanov K; Kolz CL; Hakobyan T; Dong F; Newby BZ; Chilian WM; Yin L
Basic Res Cardiol; 2017 Jul; 112(4):41. PubMed ID: 28540527
[TBL] [Abstract][Full Text] [Related]
9. Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition.
Huang G; Cheng Z; Hildebrand A; Wang C; Cimini M; Roy R; Lucchese AM; Benedict C; Mallaredy V; Magadum A; Joladarashi D; Thej C; Gonzalez C; Trungcao M; Garikipati VNS; Elrod JW; Koch WJ; Kishore R
Theranostics; 2022; 12(9):4415-4430. PubMed ID: 35673580
[No Abstract] [Full Text] [Related]
10. Mesenchymal stem cell-derived extracellular vesicles alone or in conjunction with a SDKP-conjugated self-assembling peptide improve a rat model of myocardial infarction.
Firoozi S; Pahlavan S; Ghanian MH; Rabbani S; Barekat M; Nazari A; Pakzad M; Shekari F; Hassani SN; Moslem F; Lahrood FN; Soleimani M; Baharvand H
Biochem Biophys Res Commun; 2020 Apr; 524(4):903-909. PubMed ID: 32057366
[TBL] [Abstract][Full Text] [Related]
11. Stem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue.
Waters R; Alam P; Pacelli S; Chakravarti AR; Ahmed RPH; Paul A
Acta Biomater; 2018 Mar; 69():95-106. PubMed ID: 29281806
[TBL] [Abstract][Full Text] [Related]
12. Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model.
Monguió-Tortajada M; Prat-Vidal C; Martínez-Falguera D; Teis A; Soler-Botija C; Courageux Y; Munizaga-Larroudé M; Moron-Font M; Bayes-Genis A; Borràs FE; Roura S; Gálvez-Montón C
Theranostics; 2022; 12(10):4656-4670. PubMed ID: 35832072
[No Abstract] [Full Text] [Related]
13. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model.
Bian S; Zhang L; Duan L; Wang X; Min Y; Yu H
J Mol Med (Berl); 2014 Apr; 92(4):387-97. PubMed ID: 24337504
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles enriched with miR-150 released by macrophages regulates the TP53-IGF-1 axis to alleviate myocardial infarction.
Zheng S; Gong M; Chen J
Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H969-H979. PubMed ID: 33164579
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts.
Lima Correa B; El Harane N; Gomez I; Rachid Hocine H; Vilar J; Desgres M; Bellamy V; Keirththana K; Guillas C; Perotto M; Pidial L; Alayrac P; Tran T; Tan S; Hamada T; Charron D; Brisson A; Renault NK; Al-Daccak R; Menasché P; Silvestre JS
Cardiovasc Res; 2021 Jan; 117(1):292-307. PubMed ID: 32049348
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles derived from myocardial infarction plasma inhibit BMSCs apoptosis and enhance cardiac function via AKT signaling pathway.
Jin P; Ding L; Wang L; Jiang S; Weng J; Gao Y; Fan J; Sun LZ
Int Immunopharmacol; 2021 Jul; 96():107730. PubMed ID: 34020395
[TBL] [Abstract][Full Text] [Related]
17. Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair.
Avolio E; Meloni M; Spencer HL; Riu F; Katare R; Mangialardi G; Oikawa A; Rodriguez-Arabaolaza I; Dang Z; Mitchell K; Reni C; Alvino VV; Rowlinson J; Livi U; Cesselli D; Angelini G; Emanueli C; Beltrami AP; Madeddu P
Circ Res; 2015 May; 116(10):e81-94. PubMed ID: 25801898
[TBL] [Abstract][Full Text] [Related]
18. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
[TBL] [Abstract][Full Text] [Related]
19. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.
Fitzpatrick JR; Frederick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Gambogi AJ; Liu JP; Paulson EC; Woo YJ
J Thorac Cardiovasc Surg; 2010 Sep; 140(3):667-76. PubMed ID: 20363480
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis after acute myocardial infarction.
Wu X; Reboll MR; Korf-Klingebiel M; Wollert KC
Cardiovasc Res; 2021 Apr; 117(5):1257-1273. PubMed ID: 33063086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
